WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Orgenesis Inc. • October 27th, 2022 • Pharmaceutical preparations • Maryland
This Warrant is issued to Yehuda Nir, or its registered assigns (including any successors or assigns, the “Lender”), pursuant to that certain Extension to the Convertible Loan Agreement, dated as of October 23, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Lender thereunder (the “Extenstion”) and is subject to the terms and conditions of the Extenstion.
Convertible Loan Extension AgreementConvertible Loan Extension Agreement • October 27th, 2022 • Orgenesis Inc. • Pharmaceutical preparations
This Convertible Loan Extension Agreement (“Extension”) is entered into as of October23, 2022 (the “Extension Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Yehuda Nir (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”. Any term not defined herein shall have the meaning ascribed to it in the CN (as defined below).
AMENDMENT, CONSENT AND WAIVER AGREEMENTConsent And • October 27th, 2022 • Orgenesis Inc. • Pharmaceutical preparations
This Amendment, Consent and Waiver Agreement (the “Agreement”) is entered into as of October 23, 2022 (the “Effective Date”), by and between Orgenesis Inc. (the “Corporation”) and the investors listed on the signature page hereto (“PIPE Investors”) that acquired shares of common stock of the Corporation (the “Common Stock”) pursuant to that certain Securities Purchase Agreement, dated as of March 30, 2022 (the “SPA”). The Corporation and PIPE Investors may each be referred to herein as a “Party,” and collectively as the “Parties”.
Convertible Loan Extension AgreementConvertible Loan Extension Agreement • October 27th, 2022 • Orgenesis Inc. • Pharmaceutical preparations
This Convertible Loan Extension Agreement (“Extension”) is entered into as of October 23, 2022 (the “Extension Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Ricky Neumann (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”. Any term not defined herein shall have the meaning ascribed to it in the CN (as defined below).
